Inovio Pharmaceuticals Inc. (INO) Social Stream
Inovio Pharmaceuticals Inc (INO) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering INO.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 19 months, INO's average price target has gone down $2.12.
INO reports an average of 91.7% for its upside potential over the past 19 months.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
INO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
INO's average broker recommendation rating improved by 0.05 over the prior 30 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The variance in analysts' estimates of INO is less than -199.46% of all US stocks.
- INO has a greater upside potential (average analyst target price relative to current price) than 276.87% of stocks in the mid market cap category.
- Inovio Pharmaceuticals Inc's average analyst price target is greater than 31.19% of stocks in the mid market cap category.
- Inovio Pharmaceuticals Inc's number of analysts covering the stock is greater than 220.89% of Healthcare stocks.
In the Medical Equipment industry, NTUS, VERO and IART are the three stocks most similar to Inovio Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding INO using the data that counts. Try POWR Ratings for free.